| 01 Sept, 10:59 am | other | 1 | Zydus Lifesciences provides general updates to the exchange without disclosing any specific financial or operational material events. | nse |
| 31 Aug, 10:46 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 31 Aug, 10:43 am | other | 2 | Zydus announces positive topline results from a completed Phase II(b) clinical trial of Saroglitazar Mg in MASH. | nse |
| 26 Aug, 11:15 am | — | … | Zydus Lifesciences Ltd - 532321 - Incorporation Of A Wholly Owned Subsidiary In Gift City, Gandhinagar, Gujarat | bse |
| 26 Aug, 11:12 am | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 25 Aug, 05:40 pm | — | … | Zydus Lifesciences Ltd - 532321 - ESG Rating | bse |
| 25 Aug, 05:02 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 24 Aug, 07:34 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015'. | nse |
| 23 Aug, 12:39 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 23 Aug, 12:33 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 21 Aug, 06:01 pm | — | … | Zydus Lifesciences Ltd - 532321 - ESG Rating | bse |
| 21 Aug, 05:57 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 21 Aug, 01:55 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 Aug, 01:52 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity". | nse |
| 18 Aug, 02:59 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Aug, 02:55 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Transcript | nse |
| 11 Aug, 08:28 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 11 Aug, 08:08 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 11 Aug, 07:52 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 11 Aug, 07:46 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 11 Aug, 07:07 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding 'Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015'. | nse |
| 11 Aug, 06:52 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 11, 2026, titled "Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency- Associated Lung Disease (AATD-LD)". | nse |
| 11 Aug, 01:30 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 11, 2026, titled "Press Release". | nse |
| 11 Aug, 01:29 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Aug, 01:27 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 11 Aug, 01:27 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 11 Aug, 01:24 pm | — | … | Zydus Lifesciences Ltd - 532321 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended On June 30, 2026 | bse |
| 11 Aug, 01:24 pm | — | … | Zydus Lifesciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 11 Aug, 01:22 pm | — | … | Zydus Lifesciences Ltd - 532321 - Unaudited Financial Results For The Quarter Ended On June 30, 2026 | bse |
| 10 Aug, 03:23 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Aug, 03:19 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 10, 2026, titled "Zydus launches REVAHALE , India s first once-daily nebulised LAMA for COPD". | nse |
| 04 Aug, 03:12 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Aug, 03:08 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity". | nse |
| 01 Aug, 02:42 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Zydus receives EIR from the USFDA for its injectable facility with VAI classification". | nse |
| 01 Aug, 02:38 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jul, 12:30 pm | — | … | Zydus Lifesciences Ltd - 532321 - Receipt Of Order From The Office Of The Superintendent Of Stamps, Gandhinagar, Gujarat | bse |
| 29 Jul, 12:27 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |
| 25 Jul, 04:08 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about Disruption of Operations | nse |
| 25 Jul, 04:04 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances | bse |
| 23 Jul, 10:07 am | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Jul, 10:04 am | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 23, 2026, titled "Zydus receives approval for Phase III trial of Desidustat in patients with Sickle Cell Disease, to be conducted in collaboration with ICMR". | nse |
| 20 Jul, 12:54 pm | — | … | Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30, 2026. | bse |
| 15 Jul, 08:34 am | — | … | Zydus Lifesciences Ltd - 532321 - Reply To The Clarification Sought From The Company | bse |
| 14 Jul, 08:30 pm | — | … | The Exchange has sought clarification from Zydus Lifesciences Limited with respect to recent news item captioned Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute. The response from the Company is attached. | nse |
| 14 Jul, 05:46 pm | — | … | The Exchange has sought clarification from Zydus Lifesciences Limited with respect to recent news item captioned Delhi HC Temporarily Restricts Supply Of Zydus Cancer Drug Ikra In AbbVie Patent Dispute. The response from the Company is awaited. | nse |
| 10 Jul, 02:02 pm | — | … | Zydus Lifesciences Ltd - 532321 - Reg. 34 (1) Annual Report. | bse |
| 03 Jul, 12:21 pm | — | … | Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 03, 2026, titled "Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test (MCD) in India". | nse |
| 03 Jul, 12:16 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jun, 02:36 pm | — | … | Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 29 Jun, 02:31 pm | — | … | Zydus Lifesciences Limited has informed the Exchange about General Updates | nse |